Recombinant Human HBLD1 Protein，GST

HBLD1 (Hypoxia-Associated Protein Locus D1) is a relatively new member of the family of proteins that are associated with hypoxic conditions and various cellular stress responses. Emerging evidence suggests that HBLD1 plays a pivotal role in regulating cellular processes such as apoptosis, inflammation, and cell proliferation, particularly under low oxygen conditions. Its involvement in these pathways makes it a potential target for therapeutic interventions in diseases where hypoxia is a contributing factor, such as cancer, ischemic heart disease, and neurodegenerative disorders. The recombinant expression of HBLD1 in various model systems allows researchers to dissect its functional roles and interactions with other molecular players within the hypoxia signaling network. Understanding the biochemistry of HBLD1 through recombinant protein studies could unveil novel insights into cellular adaptation mechanisms and provide a framework for developing treatments aimed at ameliorating hypoxia-related pathologies. As such, the study of HBLD1 and its recombinant forms is crucial for both fundamental research and potential clinical applications, prompting a growing interest in the scientific community to explore the therapeutic viability of this protein in the context of hypoxic stress.